BIKEN Co., Ltd. was established on September 1, 2017, as a joint venture between the BIKEN Foundation and Mitsubishi Tanabe Pharma Corporation. The company specializes in the manufacture and supply of vaccines and biological products aimed at improving public health. With a commitment to quality and innovation, BIKEN leverages its expertise to deliver critical healthcare solutions. It operates with a team of over 670 employees and is focused on producing high-quality vaccines and biopharmaceuticals.